MTBVAC induces superior antibody titers and IgG avidity compared to BCG vaccination in non-human primates

MTBVAC induces superior antibody titers and IgG avidity compared to BCG vaccination in non-human primates

The only currently licensed vaccine against tuberculosis (TB), Bacille Calmette Guérin (BCG), is insufficient to control the epidemic. MTBVAC is a live attenuated strain of Mycobacterium tuberculosis (M.tb) and is one the most advanced TB vaccine candidates in the pipeline. It is more efficacious th...

ver descrição completa

Detalhes bibliográficos
Principais autores:	Peralta-Álvarez, MP, Downward, K, White, A, Redondo Azema, H, Sibley, L, Sarfas, C, Morrison, A, Dennis, M, Diaz-Santana, D, Harris, SA, Li, S, Puentes, E, Aguilo, N, Martin, C, Sharpe, S, McShane, H, Tanner, R
Formato:	Journal article
Idioma:	English
Publicado em:	Nature Research 2024

Registros relacionados

MTBVAC induces superior antibody titers and IgG avidity compared to BCG vaccination in non-human primates
por: Marco Polo Peralta-Álvarez, et al.
Publicado em: (2024-11-01)

Low-dose M.tb infection but not BCG or MTBVAC vaccination enhances heterologous antibody titres in non-human primates
por: Marco Polo Peralta Alvarez, et al.
Publicado em: (2024-05-01)

Low-dose M.tb infection but not BCG or MTBVAC vaccination enhances heterologous antibody titres in non-human primates
por: Alvarez, MPP, et al.
Publicado em: (2024)

Evaluation of the immunogenicity and efficacy of BCG and MTBVAC vaccines using a natural transmission model of tuberculosis
por: Alvaro Roy, et al.
Publicado em: (2019-10-01)

Development of a non-human primate BCG infection model for the evaluation of candidate tuberculosis vaccines
por: Harris, S, et al.
Publicado em: (2017)

MTBVAC from discovery to clinical trials in tuberculosis-endemic countries
por: Dessislava Marinova, et al.
Publicado em: (2017-06-01)

Induction of functional specific antibodies, IgG-secreting plasmablasts and memory B cells following BCG vaccination
por: Bitencourt, J, et al.
Publicado em: (2021)

MTBVAC vaccination protects rhesus macaques against aerosol challenge with M. tuberculosis and induces immune signatures analogous to those observed in clinical studies
por: Andrew D. White, et al.
Publicado em: (2021-01-01)

Salivary anti-PGL IgM and IgA titers and serum antibody IgG titers and avidities in leprosy patients and their correlation with time of infection and antigen exposure
por: Aparecida T. Nagao-Dias, et al.

MTBVAC: Attenuating the Human Pathogen of Tuberculosis (TB) Toward a Promising Vaccine against the TB Epidemic
por: Jesus Gonzalo-Asensio, et al.
Publicado em: (2017-12-01)

The humoral immune response to BCG vaccination
por: Tanner, R, et al.
Publicado em: (2019)

Immune cell population dynamics following neonatal BCG vaccination and aerosol BCG revaccination in rhesus macaques
por: Laura Sibley, et al.
Publicado em: (2024-07-01)

Revaccination with BCG: does it work?
por: McShane, H
Publicado em: (2024)

Understanding BCG is the key to improving it.
por: McShane, H
Publicado em: (2013)

Predicting IFN-γ responses after BCG vaccination in humans from macaques: A proof-of-concept study of Immunostimulation/Immunodynamic modelling methods
por: Rhodes, S, et al.
Publicado em: (2017)

Construction and characterization of recombinant MTBVAC. HIV, a new live attenuated vaccine against HIV and tuberculosis
por: Saubi, N, et al.
Publicado em: (2018)

Serological IgG avidity test for ocular toxoplasmosis
por: Suresh S, et al.
Publicado em: (2012-01-01)

Induction of Functional Specific Antibodies, IgG-Secreting Plasmablasts and Memory B Cells Following BCG Vaccination
por: Julia Bitencourt, et al.
Publicado em: (2022-01-01)

Editorial commentary: Understanding BCG is the key to improving it
por: McShane, H
Publicado em: (2014)

Development of a primate model for tuberculosis vaccine research: IFN-gamma responses induced by BCG vaccination and M-tuberculosis infection in macaques
por: Dowall, S, et al.
Publicado em: (2007)

Role of IgG avidity in eyes with active Toxoplasma retinochoroiditis
por: Pratik Lakhmawar, et al.
Publicado em: (2024-02-01)

IgG Avidity Test in Congenital Toxoplasmosis Diagnoses in Newborns
por: Zulmirene Cardoso Fonseca, et al.
Publicado em: (2017-06-01)

Diagnosis of Toxoplasmosis in Pregnant Women by IgG Avidity Assay
por: M. Roozbehani, et al.
Publicado em: (2015-02-01)

Nanoscale spatial dependence of avidity in an IgG1 antibody
por: Agnieszka Jendroszek, et al.
Publicado em: (2021-06-01)

IV BCG Vaccination and Aerosol BCG Revaccination Induce Mycobacteria-Responsive γδ T Cells Associated with Protective Efficacy against <i>M. tb</i> Challenge
por: Alexandra L. Morrison, et al.
Publicado em: (2023-10-01)

MTBVAC-based TB-HIV vaccine is safe, elicits HIV-T cell responses, and protects against Mycobacterium tuberculosis in Mice
por: Broset, E, et al.
Publicado em: (2019)

MTBVAC-Based TB-HIV Vaccine Is Safe, Elicits HIV-T Cell Responses, and Protects against Mycobacterium tuberculosis in Mice
por: Esther Broset, et al.
Publicado em: (2019-06-01)

Longitudinal antibody titer, avidity, and neutralizing responses after SARS-CoV-2 infection
por: Jonathon M. Monroe, et al.
Publicado em: (2022-11-01)

EPSTEIN-BARR VIRUS INFECTIONS – AVIDITY TEST FOR IgG ANTIBODIES
por: Katja Strašek, et al.
Publicado em: (2001-06-01)

Diagnosis of Acute Toxoplasmosis in the First Trimester of Pregnancy by IgG Avidity
por: Afshin Azimi, et al.
Publicado em: (2022-06-01)

Measurement of the IgG Avidity Index in the Diagnosis of Clinical Toxocariasis Patients
por: Estelle Menu, et al.
Publicado em: (2021-08-01)

New live attenuated tuberculosis vaccine MTBVAC induces trained immunity and confers protection against experimental lethal pneumonia.
por: Raquel Tarancón, et al.
Publicado em: (2020-04-01)

The Humoral Immune Response to BCG Vaccination
por: Rachel Tanner, et al.
Publicado em: (2019-06-01)

Indeterminate/moderate IgG avidity during HCMV infection: comparison of methods
por: Massimo De Paschale, et al.
Publicado em: (2010-03-01)

A non-human primate in vitro functional assay for the early evaluation of TB vaccine candidates
por: Tanner, R, et al.
Publicado em: (2021)

Characterization of the Infant Immune System and the Influence and Immunogenicity of BCG Vaccination in Infant and Adult Rhesus Macaques
por: Charlotte Sarfas, et al.
Publicado em: (2021-10-01)

Evaluation of a human BCG challenge model to assess antimycobacterial immunity induced by BCG and a candidate TB vaccine, MVA85A, alone and in combination
por: Harris, S, et al.
Publicado em: (2013)

Standardization and uses of IgG antibodies avidity assays in the laboratorial diagnosis of animal toxoplasmosis
por: Luciana Regina Meireles
Publicado em: (2005-08-01)

Seropositivity of Cytomegalovirus, Rubella and Toxoplasma Gondii in Pregnant Women and IgG Avidity Tests
por: Cemal ÇİÇEK, et al.
Publicado em: (2023-04-01)

Detection of persistent low IgG avidity–an interpretative problem in the diagnosis of acute toxoplasmosis
por: Petr Kodym, et al.
Publicado em: (2023-01-01)